SCHEMBL17057937

SCHEMBL17057937

Nc1cnccc1C[S+]([O-])N1CCN(c2cnn(-c3cc(F)cc(F)c3)c(=O)c2OC2CCC(F)C2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057810 0.87 SLC2A1 (0.33) —
SCHEMBL11944548 0.85 MAPT (0.35) —
SCHEMBL11944476 0.81 SLC2A1 (0.33) —
SCHEMBL17058103 0.81 CA12 (0.32) —
SCHEMBL17058024 0.80 SLC2A1 (0.33) —
SCHEMBL11944433 0.79 POLB (0.33) —
SCHEMBL11944447 0.79 POLB (0.33) —
SCHEMBL17058353 0.78 SLC2A1 (0.30) —
SCHEMBL17057942 0.78 POLB (0.42) —
SCHEMBL11944526 0.78 MAPT (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback